REN001
REN001-202
Phase 3 small_molecule terminated
Quick answer
REN001 for Primary Mitochondrial Myopathy is a Phase 3 program (small_molecule) at OnKure Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- OnKure Therapeutics
- Indication
- Primary Mitochondrial Myopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated